Literature DB >> 23897378

Progressive multifocal leukoencephalopathy in a patient with Good's syndrome.

Olafur Sveinsson1, Henrik Matell, Lars Herrman.   

Abstract

Good's syndrome (GS) is an immunodeficiency characterised by thymoma, hypogammaglobulinemia and impaired T-cell function. The clinical symptoms are recurrent or chronic infections from common or opportunistic pathogens and diarrhoea. Encephalitis is rare, mostly associated to cytomegalovirus. We present a 65-year-old woman who developed blindness, motor deficits and cognitive changes over a 4-month period. MRI of the brain showed symmetric subcortical white matter changes in the occipital lobes, first thought to correspond to posterior reversible encephalopathy syndrome. A thymoma was found and operated. The patient had no B cells, low immunoglobulins and an inverted CD4/CD8 ratio. GS was diagnosed. In the cerbrospinal fluid >1 million JC virus copies/mL were found and a repeat MRI now showed a picture compatible with progressive multifocal leucoencephalopathy (PML). Her disease had a fatal outcome. The present case is the second reported association between GS and PML.

Entities:  

Mesh:

Year:  2013        PMID: 23897378      PMCID: PMC3736334          DOI: 10.1136/bcr-2013-009763

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

Review 1.  Common and uncommon imaging findings in progressive multifocal leukoencephalopathy (PML) with differential diagnostic considerations.

Authors:  M Horger; R Beschorner; R Beck; T Nägele; M Schulze; U Ernemann; S Heckl
Journal:  Clin Neurol Neurosurg       Date:  2012-07-06       Impact factor: 1.876

Review 2.  Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature.

Authors:  P E Tarr; M C Sneller; L J Mechanic; A Economides; C M Eger; W Strober; C Cunningham-Rundles; D R Lucey
Journal:  Medicine (Baltimore)       Date:  2001-03       Impact factor: 1.889

Review 3.  Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence.

Authors:  Theodoros Kelesidis; Otto Yang
Journal:  Clin Immunol       Date:  2010-02-10       Impact factor: 3.969

4.  Progressive multifocal leukoencephalopathy in a patient with Good's syndrome.

Authors:  Giovanna Squintani; Sergio Ferrari; Elena Bazzoli; Roberto Eleopra; Carlo La Monaca; Enrico Cagliari; Gianluigi Zanusso; Maria Cristina Mantovan; Salvatore Monaco
Journal:  Int J Infect Dis       Date:  2009-08-19       Impact factor: 3.623

  4 in total
  2 in total

1.  Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.

Authors:  Ivan Jelcic; Benoit Combaluzier; Ilijas Jelcic; Wolfgang Faigle; Luzia Senn; Brenda J Reinhart; Luisa Ströh; Roger M Nitsch; Thilo Stehle; Mireia Sospedra; Jan Grimm; Roland Martin
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

2.  Progressive multifocal leukoencephalopathy associated with thymoma with immunodeficiency: a case report and literature review.

Authors:  Tatsuya Ueno; Nobuyuki Sato; Tomoya Kon; Rie Haga; Jin-Ichi Nunomura; Kazuo Nakamichi; Masayuki Saijo; Masahiko Tomiyama
Journal:  BMC Neurol       Date:  2018-04-10       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.